A view of Fosun Group signage in Shanghai. Shanghai Fosun Pharmaceutical Co Ltd announced that it will acquire an 86.08 percent stake in Indian pharmaceutical enterprise Gland Pharma Ltd for $1.26 billion, in the largest overseas acquisition by a Chinese pharmaceutical company. Gland Pharma, one of world's largest providers of injectable generic...
The 13 winners of the first multi-year E3 Patient Safety Grants from Cardinal Health Foundation are striving to improve health outcomes for high-risk patients more quickly than the industry norm. "Cardinal Health Foundation has committed two- to three-year grants totaling nearly $2 million to help organizations improve the effectiveness, efficie
This Form 10- Q contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We are currently also considering filing an application with the U.S. Food and Drug Administration for breakthrough therapy designation for Actimab?- A and/or Iomab?- B. We are developing our cancer drugs using
ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the proposed treatment of immune deficiencies and prevention of certain infectious diseases, announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to the...
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that it has filed an international patent application with the US Patent& Trademark Office that covers transdermal extended-release formulations of clobazam, relating to the Company's AQS1302..
By a News Reporter-Staff News Editor at Insurance Weekly News Aetna and Gateway Health announced a commercial, product-based accountable care organization agreement designed to enhance coordinated patient care, lower health care costs and improve the patient experience. The ACO brings together Gateway Health, Memorial Hospital of Martinsville and
Shares of Ajanta Pharma closed 3% higher at Rs.1, 777.20 on BSE after the company announced that it has received USFDA nod for oral suspension drug. The company announced the receipt of final approval for Omeprazole and Sodium Bicarbonate Powder for Oral Suspension from US FDA. In total, Ajanta has 26 Abbreviated New Drug Application of which it ha
The US Food and Drug Administration has granted final approval to Ajanta Pharmas omeprazole and sodium bicarbonate powder for oral suspension- a heartburn drug, which helps reduce the amount of acid produced by the cells in the stomach. This new approval is part of an ever growing portfolio of products that Ajanta has developed for the US market.
BASKING RIDGE, N.J.- Caladrius Biosciences, Inc., a cell therapy company combining an industry-leading development and manufacturing services provider, PCT, with a select therapeutic development pipeline, announces today that its product candidate CLBS03 was granted Fast Track designation by the US Food and Drug Administration for the treatment of
Marylands hospitals agreed to partner with the Center for Medicare& Medicaid Innovation on a five-year experiment to test whether a shift in hospital focus from acute emergency care, surgeries and inpatient stays toward preventive, community-based care could not only control cost growth but also help people get and stay healthy, before they need a
By a News Reporter-Staff News Editor at Health& Medicine Week Cartiva, Inc. announced that the first commercial U.S. patient has received the Cartiva Synthetic Cartilage Implant following its approval by the U.S. Food and Drug Administration on July 1. The first synthetic cartilage device approved by the FDA, Cartiva provides another option for m
Cipla Ltd, Indias fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel- based company as a precondition to its $40.5 billion acquisition of Allergan Plcs generic business. The spokesperson for Cipla confirmed the p
Office Address: Department of Health and Human Services; Program Support Center; Division of Acquisition Management; 12501 Ardennes AvenueSuite 400 Rockville MD 20857. Description: Department of Health and Human Services. The Department of Health and Human Services, Substance Abuse and Mental Health Services Administration has a need for A Successf
CVS Health and Adapt Pharma today announced a new partnership that will make the opioid overdose-reversing drug NARCAN Nasal Spray more affordable for patients without insurance at CVS Pharmacy locations. Through this partnership, CVS Pharmacy patients purchasing NARCAN Nasal Spray without insurance will receive a $35 discount coupon to pur
Edge Therapeutics, Inc., a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions, today announced that the first patient has been treated in NEWTON 2, a Phase 3, multi-center, multi-national, randomized, double-blind, placebo-controlled, parallel-group study comparin
Silvergate Pharmaceuticals, Inc., leader in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Qbrelis? Oral Solution, the first and only FDA- approved Lisinopril oral solution. "We are excited to launch our second product focused on
As manufacturers are preparing to include unique device identifiers (UDIs) on more of their products this fall, the FDA has provided additional guidance on the content and form of these identification tagsand is seeking feedback on its proposal. The FDA's UDI rule, finalized in September 2013, will eventually require every medical device label
Shire Plc has announced today that the United States Food and Drug Administration (FDA) has granted Fast Track designation for SHP626 (volixibat) for an investigational treatment of adults with nonalcoholic steatohepatitis (NASH) with liver fibrosis.
Fitch Ratings has affirmed the' BBB' rating on the following bonds issued by Illinois Finance Authority on behalf of Tabor Hills:. The bonds are secured by the obligated group's gross revenues, a mortgage lien on Tabor Hills' facilities, and a debt service reserve fund. The profitability decline was due to increased pension expenses as a result of
Gland Pharma, which manufactures generic injectable pharmaceutical products, on Friday announced that Shanghai Fosun Pharmaceutical Group will acquire a majority 86% stake in the company for a consideration of $1.26 billion. Fosun is a Chinese conglomerate with interests in businesses such as wealth management, healthcare and tourism, among others,
Shanghai Fosun Pharmaceutical Group Co has agreed to buy Hyderabad- based drugmaker Gland Pharma Ltd for about $1.26 billion in what could be the largest acquisition of an Indian company by a Chinese firm. The largest Chinese deal in India had been Chinas top online-shopping company, Alibaba Group Holding Ltd. Last year, its financial affiliate put
Shanghai Fosun Pharmaceutical and Fosun. US $1,261.37 million to acquire about 79.997% equity interest in Gland Pharma Limited and. first injectable drug manufacturer in India which has been approved by the FDA and has.
The US Federal Trade Commission has approved Teva Pharmaceutical Industries takeover of the generics arm of Ireland- incorporated Allergan subject to the Israeli companys divestment of dozens of generic drugs. By selling off the drug portfolio, Teva, which is the largest generic pharmaceutical producer in the world, is settling FTC charges that its
By a News Reporter-Staff News Editor at Drug Week Galderma, a global leader focused on medical solutions in skin health, announced that its U.S. affiliate, Galderma Laboratories, L.P. received approval from the U.S. Food and Drug Administration for Differin Gel as an over-the-counter treatment for acne. It also marks the first new, FDA- approved
SUMMARY: The Food and Drug Administration is announcing the availability of the guidance entitled " General Wellness: Policy for Low Risk Devices." The guidance is intended to provide clarity to industry and FDA staff on Center for Devices and Radiological Health's compliance policy for low-risk products that promote a healthy lifestyle.